331 related articles for article (PubMed ID: 15628305)
1. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin: a new therapeutic option for fungal endocarditis.
Nevado J; De Alarcón A; Hernández A
Clin Microbiol Infect; 2005 Mar; 11(3):248. PubMed ID: 15715728
[No Abstract] [Full Text] [Related]
3. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Lye DC; Hughes A; O'Brien D; Athan E
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
[TBL] [Abstract][Full Text] [Related]
4. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
[TBL] [Abstract][Full Text] [Related]
5. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Prabhu RM; Orenstein R
Clin Infect Dis; 2004 Oct; 39(8):1253-4. PubMed ID: 15486856
[No Abstract] [Full Text] [Related]
6. Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation.
Yang SC; Shao PL; Hsueh PR; Lin KH; Huang LM
Acta Paediatr; 2006 May; 95(5):629-30. PubMed ID: 16825152
[No Abstract] [Full Text] [Related]
7. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
[TBL] [Abstract][Full Text] [Related]
8. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
Jiménez-Expósito MJ; Torres G; Baraldés A; Benito N; Marco F; Paré JC; Moreno A; Claramonte X; Mestres CA; Almela M; García de la María C; Pérez N; Schell WA; Corey GR; Perfect J; Jiménez de Anta MT; Gatell JM; Miró JM
Clin Infect Dis; 2004 Oct; 39(7):e70-3. PubMed ID: 15472836
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
10. Endocarditis caused by Candida dubliniensis.
Garcia J; Soch K; Matthew E; Surani S; Horseman MA
Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
[TBL] [Abstract][Full Text] [Related]
11. Emergence of Candida tropicalis resistant to caspofungin.
Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
[No Abstract] [Full Text] [Related]
12. Caspofungin: a potential cause of reversible severe thrombocytopenia.
Lynch J; Wong-Beringer A
Pharmacotherapy; 2004 Oct; 24(10):1408-11. PubMed ID: 15628837
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD
BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509
[TBL] [Abstract][Full Text] [Related]
14. Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin.
Sim JP; Kho BC; Liu HS; Yung R; Chan JC
Hong Kong Med J; 2005 Apr; 11(2):120-3. PubMed ID: 15815067
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
16. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
17. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
18. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2002 Dec; 50(6):1071-4. PubMed ID: 12461036
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin versus amphotericin B for invasive candidiasis.
Brown AL; Greig JR
N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
[No Abstract] [Full Text] [Related]
20. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
